Rinri Therapeutics

About:

Rinri Therapeutics is a biotechnology company developing a novel cell-based therapy.

Website: https://rinri-therapeutics.com/

Top Investors: Innovate UK, Boehringer Ingelheim Venture Fund, UCB Ventures, The Future Fund, BioCity Group

Description:

Rinri Therapeutics is a provider of private biotechnology services intended to develop advanced regenerative stem cell-based therapies for the treatment of hearing loss. The company's stem cell technology replaces damaged or dead sensory cells of the inner ear, enabling doctors to restore hearing of patients.

Total Funding Amount:

$18.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sheffield, Massachusetts, United States

Founded Date:

2018-01-01

Founders:

Marcelo Rivolta

Number of Employees:

1-10

Last Funding Date:

2021-05-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai